U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Guidance for Industry: Transition from Temporary Policy During the COVID-19 Public Health Emergency Regarding the Qualified Exemption from the Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Guidance for Industry: Transition from Temporary Policy During the COVID-19 Public Health Emergency Regarding the Qualified Exemption from the Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption April 2023

Download the Final Guidance Document
Final
Docket Number:
FDA-2023-D-1031
Issued by:
Guidance Issuing Office
Center for Food Safety and Applied Nutrition

This guidance is intended for farms subject to the Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption (Produce Safety Rule) (21 CFR Part 112). For certain farms, the Produce Safety Rule provides a qualified exemption; qualified exempt farms are subject to modified rule requirements. During the COVID-19 public health emergency as declared by the Secretary of the U.S. Department of Health and Human Services (HHS), FDA provided certain temporary flexibilities related to eligibility criteria for the qualified exemption. This document communicates FDA’s current thinking on how, when the COVID-19 public health emergency expires, qualified exempt farms may transition away from those temporary policies and back to the qualified exemption eligibility criteria as established in the Produce Safety Rule. 

FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe our current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in FDA guidances means that something is suggested or recommended, but not required.

Download the Guidance

Related Information

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2023-D-1031.

 
Back to Top